MHH Logo




Just I, Hofmann F, Genth H, Gerhard R.

Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.

Int J Med Microbiol. 2001 Sep;291(4):243-50.



Schnittler HJ, Schneider SW, Raifer H, Luo F, Dieterich P, Just I, Aktories K.

Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress.

Pflugers Arch. 2001 Aug;442(5):675-87.



Gülke I, Pfeifer G, Liese J, Fritz M, Hofmann F, Aktories K, Barth H.

Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.

Infect Immun. 2001 Oct;69(10):6004-11.



Yang SN, Yu J, Mayr GW, Hofmann F, Larsson O, Berggren PO.

Inositol hexakisphosphate increases L-type Ca2+ channel activity by stimulation of adenylyl cyclase.

FASEB J. 2001 Aug;15(10):1753-63.



Klussmann E, Tamma G, Lorenz D, Wiesner B, Maric K, Hofmann F, Aktories K, Valenti G, Rosenthal W.

An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells.

J Biol Chem. 2001 Jun 8; 276(23): 20451-7.



Dreikhausen U, Varga G, Hofmann F, Barth H, Aktories K, Resch K, Szamel M.

Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.

Eur J Immunol. 2001 May; 31(5): 1610-9.



Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K.

Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells.

J Biol Chem. 2001 Apr 6; 276(14): 10670-6.



Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva A, Aktories K, Bhakdi S.

Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3185-90.



Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I.

A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3.

J Biol Chem 2001 Mar 23;276(12):9537-42



Bigalke H, Wohlfarth K, Irmer A, Dengler R.

Botulinum A toxin: Dysport improvement of biological availability.

Exp Neurol. 2001 Mar;168(1):162-70.



Rollnik JD, Wohlfarth K, Dengler R, Bigalke H.

Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.

Neurol Clin Neurophysiol. 2001;2001(3):2-4.